Back
Windtree Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
WINT
Windtree Therapeutics
Last Price:
$1.25
Seasonality Move:
-6.37%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WINT is experiencing slight buying pressure.
Windtree Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.77 | Buy |
20-day SMA: | 0.64 | Buy |
50-day SMA: | 0.72 | Buy |
200-day SMA: | 14.24 | Sell |
8-day EMA: | 0.58 | Buy |
20-day EMA: | 0.31 | Buy |
50-day EMA: | 0.14 | Buy |
200-day EMA: | 0.04 | Buy |
Windtree Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.2 | Buy |
Relative Strength Index (14 RSI): | 60.54 | Buy |
Chaikin Money Flow: | 10860378 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.48 - 0.8) | Buy |
Bollinger Bands (100): | (0.46 - 2.04) | Sell |
Windtree Therapeutics Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Windtree Therapeutics Stock
Is Windtree Therapeutics Stock a Buy?
-
Windtree Therapeutics share price is 0.90 while WINT 8-day simple moving average is 0.77, which is a Buy signal.
-
The stock price of WINT is 0.90 while Windtree Therapeutics 20-day SMA is 0.64, which makes it a Buy.
-
Windtree Therapeutics 50-day simple moving average is 0.72 while WINT share price is 0.90, making it a Buy technically.
-
WINT stock price is 0.90 and Windtree Therapeutics 200-day simple moving average is 14.24, creating a Sell signal.
WINT Technical Analysis vs Fundamental Analysis
Sell
48
Windtree Therapeutics (WINT)
is a Sell
Is Windtree Therapeutics a Buy or a Sell?
-
Windtree Therapeutics stock is rated a SellThe current Windtree Therapeutics [WINT] share price is $0.90. The Score for WINT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Windtree Therapeutics Stock Info
Market Cap:
3.3M
Price in USD:
0.90
Share Volume:
49.2M
Windtree Therapeutics 52-Week Range
52-Week High:
737.44
52-Week Low:
0.36
Sell
48
Windtree Therapeutics (WINT)
is a Sell
Windtree Therapeutics Share Price Forecast
-
What is the Windtree Therapeutics stock price today?The Windtree Therapeutics stock price is 0.90 USD today.
-
Will WINT stock go up or go down?Windtree Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Windtree Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Windtree Therapeutics is overvalued.
Is Windtree Therapeutics Stock a Buy?
-
Windtree Therapeutics share price is 0.90 while WINT 8-day exponential moving average is 0.58, which is a Buy signal.
-
The stock price of WINT is 0.90 while Windtree Therapeutics 20-day EMA is 0.31, which makes it a Buy.
-
Windtree Therapeutics 50-day exponential moving average is 0.14 while WINT share price is 0.90, making it a Buy technically.
-
WINT stock price is 0.90 and Windtree Therapeutics 200-day simple moving average is 0.04, creating a Buy signal.
Fundamental Analysis of Windtree Therapeutics
Is Windtree Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $313.50 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Windtree Therapeutics
Should I short Windtree Therapeutics stock?
-
WINT Moving Average Covergence Divergence (MACD) indicator is 0.2, suggesting Windtree Therapeutics is a Buy
-
Windtree Therapeutics Relative Strength Index (RSI) is 60.54, which suggest Windtree Therapeutics is overbought
-
The Bollinger Bands (25) for Windtree Therapeutics is (0.48 - 0.8), which suggest Windtree Therapeutics is a Sell
-
The Bollinger Bands (100) for Windtree Therapeutics is (0.46 - 2.04), which suggest Windtree Therapeutics is a Sell
* Windtree Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.